{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-017937","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.390982+00:00","generated_at":"2026-06-24T07:52:11.922680+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ultralife Q2 revenue up 20% to $32.1M; net income falls to $0.5M from $0.8M","bullets":["Revenue $32.1M (+20% YoY); net income $0.5M ($0.03 diluted EPS) vs $0.8M ($0.05) prior year.","Operating income $0.8M vs $1.1M; gross margin 23.8% vs 27.1% on supply chain disruption and inflation.","Battery & Energy sales +31.8% to $30.1M, boosted by Excell acquisition ($6.6M) and commercial growth; Communications Systems -49% to $2.0M on supply delays.","Adjusted EBITDA flat at $2.2M (6.8% of sales vs 8.2%).","CEO cites supply chain constraints delaying govt/defense shipments; expects continued challenges in H2."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-017937","json":"https://secwatch.observer/filing/0001437749-22-017937.json","markdown":"https://secwatch.observer/filing/0001437749-22-017937.md","text":"https://secwatch.observer/filing/0001437749-22-017937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774922017937/0001437749-22-017937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774922017937/ulbi20220727_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:52:11.922680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}